Histological assessment of treatment effect in lymph node-positive breast cancer after neoadjuvant chemotherapy
{{output}}
Aims: Neoadjuvant chemotherapy (NACT) is becoming the standard of care for lymph node (LN)-positive breast cancers. Residual disease in the breast and LN serves as a critical prognostic indicator and guides adjuvant therapy. The ... ...
